Day: September 26, 2017

Meet our new CEO

September 26, 2017 No Comments

Good news for Vasalgel! Ed Gillis has joined the team as CEO of Revolution Contraceptives, LLC, the social venture company that is developing Vasalgel under

Read More »
We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

CombatCovid.HHS.Gov

Learn More

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today

Learn More
Back to home page